Creatinine-based non-phospholipid vesicular carrier for improved oral bioavailability of Azithromycin.

about

Creatinine-based non-phospholipid vesicular carrier for improved oral bioavailability of Azithromycin.

Item

http://www.wikidata.org/entity/Q53528770

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Creatinine-based non-phospholi ...... oavailability of Azithromycin.

@en

Creatinine-based non-phospholi ...... oavailability of Azithromycin.

@nl

type

Item

label

Creatinine-based non-phospholi ...... oavailability of Azithromycin.

@en

Creatinine-based non-phospholi ...... oavailability of Azithromycin.

@nl

prefLabel

Creatinine-based non-phospholi ...... oavailability of Azithromycin.

@en

Creatinine-based non-phospholi ...... oavailability of Azithromycin.

@nl

P1476

Creatinine-based non-phospholi ...... oavailability of Azithromycin.

@en

P2093

Farid Ahmed

http://www.w3.org/2001/XMLSchema#string

Imdad Ali

http://www.w3.org/2001/XMLSchema#string

Mohammad Shoaib

http://www.w3.org/2001/XMLSchema#string

Muhammad Imran

http://www.w3.org/2001/XMLSchema#string

Muhammad Raza Shah

http://www.w3.org/2001/XMLSchema#string

Shafi Ullah

http://www.w3.org/2001/XMLSchema#string

Syed Wadood Ali Shah

http://www.w3.org/2001/XMLSchema#string

P2860

Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives

Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.

Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil.

Recent technological advances in oral drug delivery - a review.

Lymphatic targeting with nanoparticulate system.

Impact of solid state properties on developability assessment of drug candidates.

Solubilizing excipients in oral and injectable formulations.

Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.

Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.

Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.

P304

1011-1022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/03639045.2017.1291667

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28157445

http://www.w3.org/2001/XMLSchema#string

P921

azithromycin